Purpose Both 131 I-and 123 I-labeled meta -iodobenzylguanidine (MIBG) have been widely used in the clinic for targeted imaging of the norepinephrine transporter (NET). The human NET (hNET) gene has been imaged successfully with Results The fluorination efficacy on benzonitrile was predominantly determined by the position of the trimethylammonium group. The para-isomer afforded higher yields (75±7 %) than meta -isomer (21±5 %). The reaction of [ 
F]fluorobenzylamine with 1H-pyrazole-1-carboximidamide was more efficient than with 2-methyl-2-thiopseudourea. The overall radiochemical yields (decay-corrected) were 11±2 % (n =12) for [ 18 
F]MFBG and 41±12 % (n =5
)
Introduction
The human norepinephrine transporter (hNET) is a transmembrane protein (617 amino acids) that functions as a rapid norepinephrine reuptake system located at or near presynaptic terminals and terminates noradrenergic signaling by rapid reuptake of neuronally released norepinephrine [1] . The in vivo expression of NET is almost exclusively restricted to the central and peripheral sympathetic nervous system [2] . Thus, hNET has recently been suggested as a human reporter gene because of its localized expression in the body [3, 4] . An additional advantage of hNET as a human reporter gene is the availability and established efficacy of several different radiotracers for clinical imaging of endogenous hNET expression. They include different radioiodine-and radiobrominelabeled benzylguanidine analogs. For example, metaiodobenzylguanidine (MIBG) is a metabolically stable analog of norepinephrine, and 131 I-labeled MIBG has been widely used for targeted imaging using single photon emission computed tomography (SPECT) or planar imaging and treatment of hNET-expressing cancer for several decades [5] . Although MIBG labeled with 131 I (T 1/2 =8.04 days; E β =606 keV, 89 %; Eγ = 364 keV, 81 %) is still used for targeted radiotherapy [5, 6] [19] , and LMI1195 [20] , have already been developed for imaging hNET expression in cancer and for imaging cardiac dysfunction. Many of these ligands were designed to have a logP value similar to that of MIBG, with the objective of achieving an in vitro uptake and in vivo distribution similar to that of MIBG. Specific accumulation of these agents in hNET-expressing SK-K-SH neuroblastoma cells has been demonstrated. However, none of the above radioligands were evaluated for imaging hNET expression in xenografts, nor was the optimal time for imaging determined (in order to achieve maximum target to background ratios). Furthermore, none of these radioligands have ever been tested or utilized for PET imaging of hNET reporter gene transduced cells or xenografts.
The focus of the study reported here was to determine whether an 18 F-labeled MIBG analog could be synthesized with a reasonable yield for clinical imaging, and whether the resultant PET images of hNET expression would be optimal within 1-4 h after administration of the radiotracer. (Fig. 1 ) that was modified from previously published methods [13, 22] . Dry tetrabutylammonium [ 190 μl) . Samples, in triplicate, were vigorously shaken for 2 h at room temperature to reach equilibrium. Then the samples were centrifuged (5 min at 2,000 rpm) and radioactivity in 50-μl aliquots from each of the aqueous and the organic phase was measured with the gamma counter. The distribution coefficient (logD) was calculated using the formula: logD= log 10 (counts in octanol layer/counts in PBS layer). added to 190 μl of human or mouse plasma. Samples, in triplicate, were gently shaken at 37°C for 0.5 h. Then the samples were centrifuged for 10 min at 9,000 rpm in 0.5 ml ultrafiltration tubes (Millipore, Bedford, MA, USA). The radioactivity in 20 μl of the plasma before filtration (to determine total added radioactivity) and 20 μl of ultrafiltrate (to determine the activity that was not bound to plasma protein) were measured in a gamma counter.
Plasma protein binding
In vitro uptake in hNET-transduced and wild-type C6 cells C6-hNET and C6-WT cells were cultured in DMEM HG cell medium. Cells (1.0×10 6 in a total volume of 1.0 ml cell medium) in triplicate were mixed with [
18 F]MFBG, [ 
Statistical analysis
Data calculated using Microsoft Excel are expressed as mean ± SD. Student's unpaired t test (GraphPad Prism 5, San Diego, CA, USA) was used to determine statistical significance at the 95 % confidence level. Differences with p values <0.05 were considered to be statistically significant. (Fig. 1) (Fig. S1) .
Results

Synthesis of [
The overall radiochemical yield of [ 
Lipophilicity (logD) and plasma protein binding
The logD values (Table 2) Table 2 ). The IC 50 values were 1.72±0.58 μM for MIBG, 7.2±0.5 μM for PIBG, 9.8±2.5 μM for PFBG, and 4.86± 0.59 μM for MFBG, respectively. Halogenation on the paraposition resulted in a lower affinity than halogenation on the meta-position. Furthermore, the substitution of fluorine for iodine on the meta-position caused a ∼2.8-fold loss in competitive affinity (Table 2 ). Typical competitive uptake curves are shown in Fig. S2 .
In vitro uptake in hNET-transduced and wild-type C6 rat glioma cells
The uptake of all four ligands was significantly higher in hNET-transduced C6 compared to C6-WT cells (Fig. 2) . The number of independent studies is given in parentheses; with triplicates in each experiment. NT not tested and 4 h p.i. (Figs. 3 and 4) . In contrast, [
124 I]MIBG PET imaging visualized the C6-hNET xenografts best at 24 h or later (Figs. 3c and 4c ). ROI measurements of radioactivity of all three ligands in the xenografts (obtained from the R4 PET images) showed significantly higher uptake in C6-hNET than in C6-WT xenografts at 1 and 4 h p.i. (Fig. 3) , which is consistent with the results obtained from the biodistribution studies (Table 3) . The ROI analysis also demonstrated that the accumulation of [ (Fig. 3a, b) , whereas the radioactivity levels were similar at 4 h (p = 0.40). (Fig. 3) . A comparison of PET image-based tumor to intestine signal ratios showed that these values for [ (Fig. 3b) . (Fig. 3c) .
Since the accumulation of [
18 F]MFBG in C6-hNET xenografts (Fig. 3a) was essentially the same at 1 and 4 h p.i. (p = 0.75), these observations suggested that the accumulation of [ (Fig. 3a, b) . Another important observation is the more rapid clearance of 18 F]MFBG was excreted predominantly through the urinary system (Fig. 3) . The higher levels of [
I]/[
124 I]MIBG in the liver and intestine suggest a slower clearance by the hepatobiliary system, and the higher levels of radioactivity in the stomach suggest deiodination of MIBG (Table 3) .
Discussion
Imaging the norepinephrine transporter (NET) has been used to diagnose and identify the extent of neuroendocrine tumors [5, 7, 24] and to document sympathetic nervous system dysfunction in congestive heart failure and other heart diseases [2, 25] (Fig. 1) was utilized. The overall radiochemical yields for both [ 18 F]MFBG and [ 18 F]PFBG were slightly higher than the published results [13] as a result of a shorter reaction time (50 versus 60 min) and slightly higher yields in [13] . In addition, our IC 50 value for MIBG uptake was significantly lower than that obtained with MFBG and PFBG. Nevertheless, the in vitro uptake of all three tracers in C6-hNET cells The projection images are from the same animals shown in Fig. 3 . A color threshold was optimized to visualize the C6-hNET tumor (white arrow) on the projection image; the C6 wild-type tumor (pink arrow) was not visualized was highly specific as demonstrated by the low uptake in C6 wild-type cells and by the effective blocking of uptake in C6-hNET cells with excess of MIBG.
In vivo validation
The in vivo PET imaging studies showed that both [ ]PFBG displayed differences in heart and adrenal uptake [13] in the mice.
In contrast to the in vitro uptake data, [ ]MFBG has a lower affinity to NET, but less serum protein binding due to its higher hydrophilicity resulting in a higher free, unbound fraction.
